SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lönnberg Lina)
 

Search: WFRF:(Lönnberg Lina) > (2012-2014) > Patients with anaem...

  • Lönnberg, MariaUppsala universitet,Analytisk kemi (author)

Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • Elsevier BV,2013
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-202020
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-202020URI
  • https://doi.org/10.1016/j.jpba.2013.04.009DOI
  • https://res.slu.se/id/publ/56192URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The primary production site of erythropoietin (EPO) is shifted from the liver to the kidney shortly after birth. Under conditions of lost or reduced kidney production, it is valuable to measure the production capacity of the liver. However, there is a lack of urine or serum based methods that can distinguish endogenous EPO produced in different cell types. Here is presented a method based on chromatographic interaction with the lectin wheat germ agglutinin (WGA) that can distinguish presumably liver-produced EPO, found in anaemic patients receiving epoetin and darbepoetin, from kidney-produced EPO found in healthy individuals.All the tested samples from haemodialysis patients with end-stage renal disease showed a presence of liver EPO. In some samples, the liver-produced EPO made up 90–100% of total EPO at a concentration of 8–10 ng/L in urine, which indicates that the liver has a quite high production capacity, although not adequate for the degree of anaemia.This glycoform analysis has made it possible to affirm that some anaemic patients can increase their liver-production of EPO. The use of such a method can give better insight into the regulation of non-renal endogenous EPO production, a potential source of EPO intended to replace administration of exogenous EPO.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Garle, MatsDoping Control Laboratory, Karolinska University Hospital, Stockholm, Sweden (author)
  • Lönnberg, LinaSwedish University of Agricultural Sciences,Sveriges lantbruksuniversitet,Institutionen för ekologi,Department of Ecology(Swepub:slu)49546 (author)
  • Birgegård, GunnarUppsala universitet,Hematologi(Swepub:uu)gunnarbg (author)
  • Uppsala universitetAnalytisk kemi (creator_code:org_t)
  • Sveriges lantbruksuniversitet

Related titles

  • In:Journal of Pharmaceutical and Biomedical Analysis: Elsevier BV81-82, s. 187-1920731-70851873-264X

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view